Pyridine diimine iron complex and preparation method and application thereof
A pyridinediimide iron series, pyridinediimine technology, applied in the direction of iron organic compounds, iron group organic compounds without C-metal bonds, hydrocarbons, etc., can solve the problem of obtaining low molecular weight, highly branched oily The distribution of polymers and oligomerization products is not very ideal, and it is difficult to meet the requirements of ethylene oligomerization, so as to achieve the effect of increasing ethylene insertion rate, increasing instability, and accelerating insertion rate
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] (1) Synthesis of pyridine diimine ligand L1:
[0039]
[0040] Dissolve 2-chloro-4-fluoro-6-benzhydrylaniline (1.25g, 4.0mmol) and 2,6-pyridinedicarbonyl chloride (0.41g, 2.0mmol) in 20ml of methanol, add formic acid under stirring 0.2ml, after reflux reaction at 55°C for 24 hours, the solvent was removed to obtain a crude product, which was then washed with C 2 h 5 OH / CH 2 Cl 2 (v / v=15:2) The mixed solvent was recrystallized to precipitate a solid precipitate, which was filtered and dried to obtain 1.36 g of the ligand with a yield of 86%.
[0041] 1 H NMR (400MHz, CDCl 3 ,ppm):δ8.20(d,J=8.4Hz,2H,Py-m-H),8.10(t,1H,Py-p-H),7.68(s,2H,Aryl-H),7.30(m,8H, Ph-H),7.21(m,4H,Ph-H),7.14(m,8H,Ph-H), 6.75(s,2H,Aryl-H),5.48(s,2H,-CHPh 2 ). 13 C NMR (100MHz, CDCl 3, ppm): δ163.3, 152.6, 150.5, 144.9 (C=N), 143.4, 139.5, 136.2, 129.9, 129.2, 128.2, 126.2, 116.6, 114.6, 56.1 (-CHPh 2 ).Anal.Calc.for C 45 h 29 Cl 4 f 2 N 3 (791.54): C, 68.28; H, 3.69; N, 5.31. Found: ...
Embodiment 2
[0051] (1) Synthesis of pyridinediimine ligand L2:
[0052]
[0053] Dissolve 2-bromo-4-fluoro-6-benzhydrylaniline (1.42g, 4.0mmol) and 2,6-pyridinedicarbonyl chloride (0.41g, 2.0mmol) in 20ml of methanol, add formic acid under stirring 0.2ml, after reflux reaction at 45°C for 12 hours, remove the solvent to obtain a crude product, and then use C 2 h 5 OH / CH 2 Cl 2 (v / v=15:2) The mixed solvent recrystallized to precipitate a solid precipitate, which was filtered and dried to obtain 1.44 g of the ligand with a yield of 82%.
[0054] 1 H NMR (400MHz, CDCl 3 ,ppm):δ8.17(d,J=8.1Hz,2H,Py-m-H),8.07(t,1H,Py-p-H),7.57(s,2H,Aryl-H),7.23-7.06(m, 20H,Ph-H),6.81(s,2H,Aryl-H),5.53(s,2H,-CHPh 2 ). 13 C NMR (100MHz, CDCl 3 , ppm): δ166.1, 155.7, 153.8, 148.2 (C=N), 146.2, 142.1, 139.7, 134.2, 132.1, 130.2, 129.2, 119.6, 117.3, 55.6 (-CHPh 2 ).Anal.Calc.forC 45 h 29 Br 2 Cl 2 f 2 N 3 (880.45): C, 61.39; H, 3.32; N, 4.77. Found: C, 61.37; H, 3.33; N, 4.78.
[0055] Its reac...
Embodiment 3
[0064] (1) Synthesis of pyridinediimine ligand L3:
[0065]
[0066] Dissolve 2-iodo-4-fluoro-6-benzhydrylaniline (1.61g, 4.0mmol) and 2,6-pyridinedicarbonyl chloride (0.41g, 2.0mmol) in 20ml of methanol, add formic acid under stirring 0.2ml, after reflux reaction at 50°C for 18 hours, the solvent was removed to obtain a crude product, which was then washed with C 2 h 5 OH / CH 2 Cl 2 (v / v=15:2) The mixed solvent recrystallized to precipitate a solid precipitate, which was filtered and dried to obtain 1.62 g of the ligand with a yield of 83%.
[0067] 1 H NMR (400MHz, CDCl 3 ,ppm):δ8.22(d,J=8.2Hz,2H,Py-m-H),8.14(t,1H,Py-p-H),7.71(s,2H,Aryl-H),7.35(m,8H, Ph-H),7.26(m,4H,Ph-H),7.17(m,8H,Ph-H), 6.79(s,2H,Aryl-H),5.57(s,2H,-CHPh 2 ). 13 C NMR (100MHz, CDCl 3 , ppm): δ164.1, 153.7, 151.0, 146.2 (C=N), 144.5, 141.3, 137.4, 131.1, 129.2, 127.3, 124.2, 114.6, 112.7, 56.1 (-CHPh 2 ).Anal.Calc.for C 45 h 29 I 2 Cl 2 f 2 N 3 (974.45): C, 55.47; H, 3.00; N, 4.31. Found: C...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



